Skip to main content
Fig. 6 | Lipids in Health and Disease

Fig. 6

From: Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases

Fig. 6

LysoPC plasma level in healthy mice and tumour bearing mice. Total LysoPC plasma levels of healthy mice (n = 4) and mice intravenously injected with B16.F10 melanoma cells; one (n = 3), two (n = 3) and three (n = 3) weeks after injection of tumour cells. LysoPC levels were determined by HPLC MS/MS analysis. Values compared by ANOVA: * p ≤ 0.05, ** p ≤ 0.01

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X